Skip to main content
SpringerLink
Log in

Are Gliomas Preventable?

  • Conference paper
Cancer Prevention

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 174))

Abstract

Gliomas are a family of primary central nervous system tumors of variable malignancy that are derived from supporting glia (astrocytes, oligodendrocytes, ependymal cells) or their progenitors/stem cells. There are two potential strategies to prevention: preventing gliomas from forming and preventing lower-grade gliomas from developing into higher-grade gliomas. Each would lower time-dependent mortality. Each also depends on an understanding of what causes gliomas so that these factors can be modulated. In this presentation, I will discuss primary prevention, chemoprevention, and screening. I will first focus on the known chromosomal, genetic, and protein changes associated with the different histologic varieties of glioma and the environmental, hereditary, and infectious/viral factors that may promote glioma development and malignant progression. I will discuss a number of clinical scenarios that eventuate from the known genetic patterns of these tumors and the changes in genetic patterns that reflect malignant progression. The basic thinking is that if one could prevent specific gene mutations and/or deletions or gains of specific chromosomes that lead to the development of low-grade (WHO 2) gliomas, then theoretically this would reduce the occurrence of high-grade (WHO 3 and 4) gliomas and hence the almost certain death that now is the fate of most patients with these tumors. In the case of de novo WHO 3 and 4 tumors, being able to prevent or counter specific gene mutations and/or the deletion of specific chromosomes would in itself reduce the occurrence of these gliomas and increase survival. Alternatively, a curative treatment for low-grade glioma that prevents these chromosomal/gene changes would prevent some glioblastomas (WHO 4) from forming and would have the same desired effect on survival. Obviously, for the latter to be achieved, we must also be able to diagnose and treat low-grade gliomas earlier.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anonymous (2005) Central Brain Tumor Registry of United States Special Data Analysis (December 15, 2005)

    Google Scholar 

  • Austin SG, Schnatter AR (1983) A cohort mortality study of petrochemical workers. J Occup Med 25:304–312

    PubMed  CAS  Google Scholar 

  • Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, Macdonald D, Stitt L, Cairncross JG (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis. Intl J Radiat Oncol Biol Phy 45:923–929

    Article  CAS  Google Scholar 

  • Beall C, Delzell E, Rodu B, Sathiakumar N, Lees PS, Breysse PN, Myers S (2001) Case-control study of intracranial tumors among employees at a petrochemical research facility. J Occup Environ Med 43:1103–1113

    PubMed  CAS  Google Scholar 

  • Carozza SE, Wrensch M, Miike R, Newman B, Olshan AF, Savitz DA, Yost M, Lee M (2000) Occupation and adult gliomas. Am J Epidemiol 152:838–846

    Article  PubMed  CAS  Google Scholar 

  • Carreon T, Butler MA, Ruder AM, Waters MA, Davis-King KE, Calvert GM, Schulte PA, Connally B, Ward EM, Sanderson WT, Heineman EF, Mandel JS, Morton RF, Reding DJ, Rosenman KD, Talaska G, Cancer B (2005) Gliomas and farm pesticide exposure in women: the Upper Midwest Health Study. Environ Health Perspect 113:546–551

    PubMed  CAS  Google Scholar 

  • Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M (2001) Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res 61:3949–3954

    PubMed  CAS  Google Scholar 

  • Davis FG, Preston-Martin S (1999) Epidemiology. Incidence and survival. In: Bigner DD, McLendon RE, Bruner JM (eds) Russell and Rubinstein’s pathology of tumors of the nervous system. Arnold, London, pp 7–11

    Google Scholar 

  • El-Zein R, Minn Y, Wrensch M, Bondy ML (2002) Epidemiology of brain tumors. In: Levin VA (ed) Cancer in the nervous system. Oxford University Press, Oxford, pp 252–268

    Google Scholar 

  • Engels EA, Sarkar C, Daniel RW, Gravitt PE, Verma K, Quezado M, Shah KV (2002) Absence of simian virus 40 in human brain tumors from northern India. Int J Cancer 101:348–352

    Article  PubMed  CAS  Google Scholar 

  • Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L (2001) Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys 51:704–710

    Article  PubMed  CAS  Google Scholar 

  • Floderus B, Persson T, Stenlund C, Wennberg A, Ost A, Knave B (1993) Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden. Cancer Causes Control 4:465–476

    Article  PubMed  CAS  Google Scholar 

  • Grayson JK (1996) Radiation exposure, socioeconomic status, and brain tumor risk in the US Air Force: a nested case-control study. Am J Epidemiol 143:480–486

    PubMed  CAS  Google Scholar 

  • Gurney JG, Mueller BA, Davis S, Schwartz SM, Stevens RG, Kopecky KJ (1996) Childhood brain tumor occurrence in relation to residential power line configurations, electric heating sources, and electric appliance use. Am J Epidemiol 143:120–128

    PubMed  CAS  Google Scholar 

  • Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS (2001) Cellular-telephone use and brain tumors. N Engl J Med 344:79–86

    Article  PubMed  CAS  Google Scholar 

  • Keles GE, Lamborn KR, Berger MS (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–745

    PubMed  CAS  Google Scholar 

  • Kheifets LI, Sussman SS, Preston-Martin S (1999) Childhood brain tumors and residential electromagnetic fields (EMF). Rev Environ Contam Toxicol 159:111–129

    PubMed  CAS  Google Scholar 

  • Kleihues P, Ohgaki H (1999) Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1:44–51

    Article  PubMed  CAS  Google Scholar 

  • Kleihues P, Ohgaki H (2000) Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol 28:164–170

    PubMed  CAS  Google Scholar 

  • Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225; discussion 226–219

    PubMed  Google Scholar 

  • Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA, Saya H (1994) Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86:344–349

    Article  PubMed  CAS  Google Scholar 

  • Kyritsis AP, Bondy ML, Hess KR, Cunningham JE, Zhu D, Amos CJ, Yung WK, Levin VA, Bruner JM (1995) Prognostic significance of p53 immunore-activity in patients with glioma. Clin Cancer Res 1:1617–1622

    PubMed  CAS  Google Scholar 

  • Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM (1996) Correlation of p53 immunoreactivity and sequencing in patients with glioma. Mol Carcinog 15:1–4

    Article  PubMed  CAS  Google Scholar 

  • Lee WJ, Colt JS, Heineman EF, McComb R, Weisenburger DD, Lijinsky W, Ward MH (2005) Agricultural pesticide use and risk of glioma in Nebraska, United States. Occup Environ Med 62:786–792

    Article  PubMed  CAS  Google Scholar 

  • Levin VA (1996) Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas. Curr Opin Oncol 8:175–177

    PubMed  CAS  Google Scholar 

  • Levin VA, Prados MD, Yung WK, Gleason MJ, Ictech S, Malec M (1992) Treatment of recurrent gliomas with eflornithine. J Natl Cancer Inst 84:1432–1437

    Article  PubMed  CAS  Google Scholar 

  • Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR (2000) Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N’-cyclohexyl-Nnitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clin Cancer Res 6:3878–3884

    PubMed  CAS  Google Scholar 

  • Levin VA, Leibel SA, Gutin PH (2001) Neoplasms of the central nervous system. In: DeVita VTJ, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 2100–2160

    Google Scholar 

  • Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethyl-ornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981–990

    PubMed  CAS  Google Scholar 

  • Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL (2004) Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 15:819–827

    Article  PubMed  Google Scholar 

  • Louis DM, Cavenee WK (2001) Molecular biology of central nervous system neoplasms. In: DeVita VTJ, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lipincott-Raven, Philadelphia, pp 2091–2099

    Google Scholar 

  • Loyant V, Jaffre A, Breton J, Baldi I, Vital A, Chapon F, Dutoit S, Lecluse Y, Loiseau H, Lebailly P, Gauduchon P (2005) Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents. Mutagenesis 20:365–373

    Article  PubMed  CAS  Google Scholar 

  • Martin JD, King DM, Slauch JM, Frisque RJ (1985) Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 53:306–311

    PubMed  CAS  Google Scholar 

  • Moss AR (1985) Occupational exposure and brain tumors. J Toxicol Environ Health 16:703–711

    Article  PubMed  CAS  Google Scholar 

  • Muller W, Afra D, Schroder R (1977a) Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir 37:75–91

    Article  CAS  Google Scholar 

  • Muller W, Afra D, Schroder R (1977b) Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with oligodendrogliomas. Acta Neurochir 39:15–25

    Article  CAS  Google Scholar 

  • Musicco M, Filippini G, Bordo BM, Melotto A, Morello G, Berrino F (1982) Gliomas and occupational exposure to carcinogens: case-control study. Am J Epidemiol 116:782–790

    PubMed  CAS  Google Scholar 

  • Musicco M, Sant M, Molinari S, Filippini G, Gatta G, Berrino F (1988) A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol 128:778–785

    PubMed  CAS  Google Scholar 

  • Neuberger JS, Ward-Smith P, Morantz RA, Tian C, Schmelzle KH, Mayo MS, Chin TD (2003) Brain cancer in a residential area bordering on an oil refinery. Neuroepidemiology 22:46–56

    Article  PubMed  Google Scholar 

  • Nomura K, Committee of Brain Tumor Registry of Japan (2003) Report of Brain Tumor Registry of Japan. Neurologia Med Chir 43:1–111

    Article  Google Scholar 

  • Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479–489

    PubMed  CAS  Google Scholar 

  • Olin RG, Ahlbom A, Lindberg-Navier I, Norell SE, Spannare B (1987) Occupational factors associated with astrocytomas: a case-control study. Am J Ind Med 11:615–625

    Article  PubMed  CAS  Google Scholar 

  • Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA (1997) Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-oncol 32:235–241

    Article  CAS  Google Scholar 

  • Preston-Martin S (1996) Epidemiology of primary CNS neoplasms. Neurol Clin 14:273–290

    Article  PubMed  CAS  Google Scholar 

  • Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D (1996) Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocom-petent patient with oligoastrocytoma. Proc Natl Acad Sci U S A 93:7352–7357

    Article  PubMed  CAS  Google Scholar 

  • Rollison DE, Utaipat U, Ryschkewitsch C, Hou J, Goldthwaite P, Daniel R, Helzlsouer KJ, Burger PC, Shah KV, Major EO (2005) Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer 113:769–774

    Article  PubMed  CAS  Google Scholar 

  • Saha S, Hoerger TJ, Pignone MP, Teutsch SM, Helfand M, Mandelblatt JS (2001) The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. Am J Prev Med 20:36–43

    Article  PubMed  CAS  Google Scholar 

  • Sakata K, Hareyama M, Komae T, Shirato H, Watanabe O, Watarai J, Takai K, Yamada S, Tsuchida E, Sakai K (2001a) Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era. Jpn J Clin Oncol 31:240–245

    Article  PubMed  CAS  Google Scholar 

  • Schiffer D, Dutto A, Cavalla P, Bosone I, Chio A, Villani R, Bellotti (1997) Prognostic factors in oligodendroglioma Canadian Journal of Neurological Sciences 24:313–319

    CAS  Google Scholar 

  • Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, Ryan P (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82:155–160

    Article  PubMed  CAS  Google Scholar 

  • Shaw EG, Scheithauer BW, O’Fallon JR (1993) Management of supratentorial low-grade gliomas. Oncology (Huntingt) 7:97–104

    PubMed  CAS  Google Scholar 

  • Shaw E, Arusell R, Scheithauer B, O’Fallon J, O’Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R (2002) Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267–2276

    Article  PubMed  CAS  Google Scholar 

  • Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26:239–244

    PubMed  CAS  Google Scholar 

  • Teta MJ, Ott MG, Schnatter AR (1991) An update of mortality due to brain neoplasms and other causes among employees of a petrochemical facility. J Occup Med 33:45–51

    Article  PubMed  CAS  Google Scholar 

  • Tynes T, Haldorsen T (1997) Electromagnetic fields and cancer in children residing near Norwegian high-voltage power lines. Am J Epidemiol 145:219–226

    PubMed  CAS  Google Scholar 

  • Winger MJ, Macdonald DR, Cairncross JG (1989) Supratentorial anaplastic gliomas in adults: The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487–493

    Article  PubMed  CAS  Google Scholar 

  • Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J (1997) Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145:581–593

    PubMed  CAS  Google Scholar 

  • Zahm SH, Devesa SS (1995) Childhood cancer: overview of incidence trends and environmental carcinogens. Environ Health Perspect 103[Suppl 6]:177–184

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuro-Oncology Unit 431, University of Texas, M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX, 77230-1402, USA

    Victor A. Levin MD

Authors
  1. Victor A. Levin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tumor-Zentrum ZeTuP St. Gallen/Chur (Tumordiagnostik, Behandlung + Prävention), Rorschacherstr. 150, CH-9006, St. Gallen, Schweiz

    Hans-Jörg Senn  & Ursula Kapp  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Levin, V.A. (2007). Are Gliomas Preventable?. In: Senn, HJ., Kapp, U. (eds) Cancer Prevention. Recent Results in Cancer Research, vol 174. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-37696-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-37696-5_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-37695-8

  • Online ISBN: 978-3-540-37696-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation